Michela Spinelli, Chief Scientific Officer

Michela Spinelli  is Chief Scientific Officer. She was awarded a PhD in Industrial Biotechnology Pharmacogenomics from the University of Milan-Bicocca (Italy) and she gained 15 years’ experience in cancer academic research.
From 2009 to 2010 she worked as researcher at Kimmel Cancer Center, Department of Urology (Philadelphia, USA). From 2010 to 2011 she moved as researcher to the San Raffaele Hospital, Department of Immunotherapy of Solid Tumors (Italy). From 2012 to 2016 she worked as post-doc at UNIMI-Bicocca (Italy) in the field of cellular biology, development of biological assay and drug discovery. She joined ADIENNE in 2016 and today is responsible for all research and development programmes.